Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Borgmann

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Cdc45 is limiting for replication initiation in humansCarsten Köhler, Dennis Koalick, Anja Fabricius, et al.
Molecular Cancer Therapeutics|July 31, 2016
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating DrugsNancy Berte, Andrea Piée-Staffa, Nadine Piecha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancerUlrike Hoeller, Kerstin Borgmann, Michael Bonacker, et al.
Oncotarget|April 25, 2015
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repairUpadhyayula Sai Srinivas, Jerzy Dyczkowski, Tim Beißbarth, et al.
Molecular Oncology|July 17, 2014
Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cellsAnnika Kötter, Kerstin Cornils, Kerstin Borgmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
DNA RepairKerstin Borgmann, Sabrina Köcher, Malte Kriegs, et al.
Cancer Letters|March 19, 2011
FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisonsLisa A Kachnic, Li Li, Loreen Fournier, et al.
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 27, 2014
Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivitySebastian Reuther, Silke Szymczak, Annette Raabe, et al.
Oncotarget|August 6, 2016
Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1Ali Bakr, Sabrina Köcher, Jennifer Volquardsen, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Cdc45 is limiting for replication initiation in humansCarsten Köhler, Dennis Koalick, Anja Fabricius, et al.
Molecular Cancer Therapeutics|July 31, 2016
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating DrugsNancy Berte, Andrea Piée-Staffa, Nadine Piecha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancerUlrike Hoeller, Kerstin Borgmann, Michael Bonacker, et al.
Oncotarget|April 25, 2015
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repairUpadhyayula Sai Srinivas, Jerzy Dyczkowski, Tim Beißbarth, et al.
Molecular Oncology|July 17, 2014
Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cellsAnnika Kötter, Kerstin Cornils, Kerstin Borgmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
DNA RepairKerstin Borgmann, Sabrina Köcher, Malte Kriegs, et al.
Cancer Letters|March 19, 2011
FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisonsLisa A Kachnic, Li Li, Loreen Fournier, et al.
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 27, 2014
Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivitySebastian Reuther, Silke Szymczak, Annette Raabe, et al.
Oncotarget|August 6, 2016
Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1Ali Bakr, Sabrina Köcher, Jennifer Volquardsen, et al.
Pageof 9